RenovoDerm Holds Executive Reimbursement Workshop

On July 25, RenovoDerm held an all-day executive reimbursement workshop led by Kathleen Schaum, President of Kathleen D. Schaum & Assoc., Inc. Ms. Schaum is a nationally recognized wound care reimbursement strategy consultant and educator with nearly 50 years of industry experience. Ms. Schaum led the RenovoDerm team in crafting its reimbursement strategy for the Phoenix Wound Care Matrix, which included coding, coverage, and payment. The seminar also focused on identifying and targeting the most applicable markets for the Phoenix and creating a detailed timeline to achieve a product launch.

The workshop was very successful. After significant dialogue with Ms. Schaum, the RenovoDerm team is now better equipped to effectively earn a strategic reimbursement code, implement a detailed sales and marketing strategy, and utilize valuable resources to maximize the company’s value.

Announcing RenovoDerm's Director of Market Development: Dawn Cornett!

We would like to welcome Dawn to the RenovoDerm team! Dawn Cornett, Director of Market Development, is a former VP of Clinical Sales at Genadyne Biotechnologies with over 20 years of experience within the healthcare field. Dawn was responsible for launching Genadyne Biotechnologies national hospital division. For 9 years, Dawn was the Executive Director of a durable medical equipment company’s wound care division. Most notably, she was responsible for achieving a multi-million-dollar division within her first two years of a new product launch. Additionally, Dawn achieved a yearly growth of over 30% and oversaw the acquisition of Wrencare’s wound division to Lincare. While at Lincare, she again launched a successful national wound care program.

RenovoDerm receives FDA approval for Phoenix Wound Matrix

Phoenix Wound Matrix (1).png
IMG_5385+(1).jpeg

Today, RenovoDerm announced that the U.S. Food and Drug Administration (FDA) has cleared its proprietary product, the Phoenix Wound Matrix, which is a wound care device that accelerates the body’s healing response, facilitates tissue growth and regeneration, reduces scar formation and enhances overall cosmesis.

The Phoenix Wound Matrix is a fully resorbable synthetic graft that closely mimics the extracellular matrix (ECM) found naturally in the body. This product will be used for the treatment of acute, chronic, and burn wounds, which continues to be a concern for both doctors and patients.

New RenovoDerm Facility

RenovoDerm recently moved into a new facility. The new facility includes 1,200 sq. feet of clean room manufacturing space in a 4,000 sq. ft. space. This facility, equipment and the quality management system are required for ISO 13485/CFR Part 820 certification by BSI.

Heal Ohio Wound Care Conference

heal ohio.png

Jed Johnson represented RenovoDerm at the 2017 Heal Ohio Wound Care Conference on Thursday, November 2nd. Heal Ohio is a statewide collaborative that aims to unite scientists, healthcare professionals, and commercial partners who share a common vision and mission to solve problems associated with wound care. In doing this, it will serve to bridge the gaps that exist between clinics, research, business, and patients.

The 2017 Heal Ohio Conference was devoted to health professional presentations and feature informative learning sessions and keynote addresses. Activities provided an atmosphere rich in collaboration and networking for both career and research advancement.